1-4 of 4
Wanting Qiang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Updated Results of a Phase I Open-Label Single-Arm Study of Dual Targeting BCMA and CD19 Fastcar-T Cells (GC012F) As First-Line Therapy for Transplant-Eligible Newly Diagnosed High-Risk Multiple Myeloma

Juan Du, Wanting Qiang, Jing Lu, Yanchun Jia, Haiyan He, Jin Liu, Pei Guo, Ying Yang, Zhongyuan Feng, Lina Jin, Xiaoqiang Fan, Jia Liu, Qi Zhang, Lianjun Shen, Lihong Weng, Wenling Li, Wei Cao
Journal: Blood
Blood (2023) 142 (Supplement 1): 1022.
https://doi.org/10.1182/blood-2023-174841
Published: 2023
Journal Articles

Phase I Open-Label Single-Arm Study of BCMA/CD19 Dual-Targeting FasTCAR-T Cells (GC012F) As First-Line Therapy for Transplant-Eligible Newly Diagnosed High-Risk Multiple Myeloma

Juan Du, Weijun Fu, Jing Lu, Wanting Qiang, Haiyan He, Jin Liu, Ying Yang, Zhongyuan Feng, Lina Jin, Xiaoqiang Fan, Jia Liu, Qi Zhang, Lianjun Shen, Lihong Weng, Wei Cao
Journal: Blood
Blood (2022) 140 (Supplement 1): 889–890.
https://doi.org/10.1182/blood-2022-162295
Published: 2022
Journal Articles

Plasma Cell-Free DNA Chromosomal Instability As Surrogate Biomarker of Treatment Response and Minimal Residual Diseases for Multiple Myeloma

Juan Du, Jr., MD, Baoan Chen, MDPhD, Wanting Qiang, Yanchun Jia, Jing Lu, MD, Lu Li, Jing Liu, Hua Jiang, MD, Ziliang Qian, Weijun Fu, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29.
https://doi.org/10.1182/blood-2020-138783
Published: 2020
Journal Articles

Cell-Free DNA Analysis Demonstrates Comprehensive Genomic Profiling and a Facile Method to Sensitively in Multiple Myeloma

Juan Du, MD PhD, Jing Lu, Wanting Qiang, Lu Li, Jin Liu, Hua Jiang, MD, Ziliang Qian, PhD, Baoan Chen, MD PhD, Weijun Fu, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5603.
https://doi.org/10.1182/blood-2018-99-116260
Published: 2018